Effect of Covid-19 on Diabetes Mellitus at Jazan Community
DOI:
https://doi.org/10.37506/ayc9nq21Keywords:
COVID-19, Diabetes mellitus.Abstract
Background: The ongoing pandemic of COVID-19 is now the major issue in global health. Evidence implies that patients with diabetes are at a higher risk of severe disease or death due to COVID-19 than individuals without diabetes. Aim to explore the effect of the coronavirus disease lockdown on diabetes patients living in JAZAN, Saudi Arabia Subject and Methods this was a cross-sectional study that was carried out among adult and adolescent diabetic people in 2020, toward COVID-19 pandemic effects on diabetic patients in jazan, who had attended Prince Mohammed bin Nasser Hospital in jazan, Saudi Arabia. The sample size taken in ; the total respondents were 110., The study population included adult and adolescent male and female diabetic patients ,Age was categorized into four subgroups, starting from the 21-35 years group to the above 46 years. Patients were asked. The results found A majority of the responders (55.5% ) were وPatients were asked fearing to contract coronavirus infection more than non-diabetic people , A majority of the responders (53.6% ) were Agree, Patients were asked Having had any online/virtual appointment during COVID-19 pandemic , found A majority of the responders (56.4% ) were Agree Patients were asked . Recommendation Further studies are needed to explore the exact psychological effect of COVID- 19 on diabetic patients. For people living with diabetes it is important to take precautions to avoid the virus if possible. The recommendations that are being widely issued to the general public are doubly important for people living with diabetes and anyone in close contact with people living with diabetes.
References
SONG, Fengxiang, et al. Emerging 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology, 2020, 295.1: 210-217.
CAO, Xuetao. COVID-19: immunopathology and its implications for therapy. Nature reviews immunology, 2020, 20.5: 269-270.
CHENG, Yichun, et al. disease is associated with in-hospital death of patients with COVID-19. Kidney International, 2020, 1.
GUO, Weina, et al. Diabetes is a risk factor for the progression and prognosis of COVID‐19. Diabetes/metabolism research and reviews, 2020, 36.7: e3319.
GUPTA, Ritesh, et al. Clinical considerations for patients with diabetes in times of COVID-19 epidemic. Diabetes & metabolic syndrome, 2020, 14.3: 211.
HUANG, Chaolin, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, 2020, 395.10223: 497-506.
HUSSAIN, Akhtar; BHOWMIK, Bishwajit; DO VALE MOREIRA, Nayla Cristina. COVID-19 and diabetes: Knowledge in progress. Diabetes research and clinical practice, 2020, 162: 108142.
JÜNI, Peter, et al. Impact of climate and public health interventions on the COVID-19 pandemic: a prospective cohort study. Cmaj, 2020, 192.21: E566-E573.
ALRAMADAN, Mohammed J., et al. Glycaemic control for people with type 2 diabetes in Saudi Arabia–an urgent need for a review of management plan. BMC endocrine disorders, 2018, 18: 1-12.
ALSHAREEF, Reem, et al. Impact of the COVID-19 lockdown on diabetes patients in Jeddah, Saudi Arabia. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020, 14.5: 1583-1587.
WU, Zunyou; MCGOOGAN, Jennifer M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. jama, 2020, 323.13: 1239-1242.
MISHRA, Paras K.; TANDON, Ritesh; BYRAREDDY, Siddappa N. Diabetes and COVID-19 risk: anmiRNA perspective. American Journal of Physiology-Heart and Circulatory Physiology, 2020, 319.3: H604-H609.
ALLAN, Maya, et al. The world health organization COVID-19 surveillance database. International Journal for Equity in Health, 2022, 21.Suppl 3: 167.
YANG, Jing, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis, 2020, 94.1: 91-95.
YANG, Jing, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis, 2020, 94.1: 91-95.
ZHANG, Jin-jin, et al. Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China. Allergy, 2020, 75.7: 1730-1741.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
https://creativecommons.org/licenses/by-nc/2.0/deed.en